Rivaroxaban
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10127 publications
Efficacy and safety of direct oral anticoagulants for the treatment of non-triple-positive antiphospholipid syndrome-associated pulmonary thromboembolism
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: September 07, 2026
A Scandinavian Perspective of the Projected Lifetime Cost-Effectiveness of Rivaroxaban Plus Aspirin in the COMPASS Trial.
Journal: Scandinavian cardiovascular journal : SCJ
Published: September 05, 2026
Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Rivaroxaban with Cobicistat or Darunavir/Cobicistat in Healthy Participants.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 04, 2026
CytoSorb Application for Successful Control of Life-Threatening Gastrointestinal Bleeding Following Rivaroxaban Administration.
Journal: The American journal of case reports
Published: September 04, 2026
Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: September 01, 2026
In advanced CKD with high CV risk, low-dose rivaroxaban vs. placebo did not reduce CV events and increased major bleeding.
Journal: Annals of internal medicine
Published: August 31, 2026
Evaluation of an Adapted Murine Electrolytic Model of Venous Injury in Wistar Rats: Histopathological Characterization and Challenges in Model Adaptation.
Journal: Cureus
Published: August 27, 2026
Case Report: Direct Oral Anticoagulants Treatment Failure for Venous Thromboembolism in the Setting of Multiple Thrombophilic Conditions.
Journal: Journal of pharmacy practice
Published: August 21, 2026
Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: August 18, 2026
Extended Anticoagulation Therapy with Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Status of Concomitant Deep Vein Thrombosis: Insights from the ONCO PE Randomized Trial.
Journal: Seminars in thrombosis and hemostasis
Published: August 14, 2026
Last Updated: 09/26/2026